The European Patent Office (EPO) has officially granted patent EP3422848B1, titled "PRESERVATION OF CELLULAR COMPONENTS FROM CELLS WITH A PRESERVATIVE." This patent, effective March 18, 2026, relates to methods for preserving cellular components and is classified under IPC codes A01N 1/02, C12M 1/00, and C12N 1/06. The designated states for this patent include a broad range of European countries.

This grant represents a new intellectual property right for the inventors and their associated entities. While this is a patent grant and not a regulatory rule imposing direct compliance obligations on companies, it signifies exclusive rights for the patent holder within the designated European states. Companies operating in the biotechnology and pharmaceutical sectors, particularly those involved in cell preservation or related technologies, should be aware of this granted patent to ensure they do not infringe upon the patent holder's exclusive rights. No immediate compliance actions are required by this notice, but legal counsel should be consulted if activities may fall within the scope of the patent's claims.